Abstract:Cellular Fn-EDA (fibronectin containing extra domain A) is expressed in activated endothelial cells and elevated in circulation in patients with cardiovascular diseases. Although global deficiency of Fn-EDA in mice improves stroke outcome, the specific contribution of plasma versus endothelium Fn-EDA in stroke outcome is currently unknown. We investigated the role of plasma versus endothelial Fn-EDA in stroke exacerbation in the comorbid condition of hyperlipidemia. We generated novel plasma Fn-EDA −/− ( Fn-EDA fl/fl Alb Cre ) and endothelial Fn-EDA −/− ( Fn-EDA fl/fl Tie2 Cre ) strains on hyperlipidemic apolipoprotein E-deficient ( ApoE −/− ) background. By following the Stroke Therapy Academic Industry Roundtable guidelines, we evaluated stroke outcome in male and female mice. Susceptibility to ischemia/reperfusion injury was evaluated in 2 different models of stroke: intraluminal monofilament and embolic model on days 1, 3, and 7. Quantitative assessment of stroke outcome was evaluated by measuring infarct volume (by magnetic resonance imaging), cerebral blood flow (by laser speckle imaging), neurological and sensory-motor outcome, and postischemic thrombo-inflammation (platelet thrombi, fibrin, neutrophil, phospho-NFκB [nuclear factor κB], TNFα [tumor necrosis factor α], and IL1β [interleukin 1β]). Stroke outcome was comparable in ApoE −/− Fn-EDA fl/fl Tie2 Cre and control ApoE −/− Fn-EDA fl/fl mice suggesting endothelial Fn-EDA does not contribute to stroke. ApoE −/− Fn-EDA fl/fl Alb Cre mice exhibited significantly smaller infarcts and improved neurological and sensory-motor outcome at days 1, 3, and 7 in monofilament and embolic models of stroke. Improved stroke outcome was concomitant with enhanced survival, and decreased postischemic thrombo-inflammatory response ( P <0.05 versus ApoE −/− Fn-EDA fl/fl ). No sex-based differences were observed. Laser speckle imaging revealed significantly improved regional cerebral blood flow at 1 hour in ApoE −/− Fn-EDA fl/fl Alb Cre mice suggesting plasma Fn-EDA promotes postischemic secondary thrombosis. Coinfusion of anti–Fn-EDA antibody with r-tPA (recombinant tissue-type plasminogen activator) in ApoE −/− mice, 1 hour after embolization, improved stroke outcome with enhanced survival, and improved neurological outcome ( P <0.05 versus r-tPA). Genetic evidence suggests that plasma Fn-EDA exacerbates stroke outcome by promoting postischemic thrombo-inflammation. Interventions targeting plasma Fn-EDA may reduce brain damage after reperfusion. Download figure Download PowerPoint

Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation

Abstract 19: Von Willebrand Factor Deficiency Improves Long Term Stroke Outcomes in Mice With Respiratory Infections

Abstract 162: Arterial Aspirate Derived Exosomes From Patients With Large Vessel Occlusion Are Associated With Increased Blood-brain Barrier Permeability, Decreased Endothelial Integrity As Well Poor Clinical And Radiographic Outcomes Following Mechanical Thrombectomy

Von Willebrand Factor Enhances Microvesicle-Induced Vascular Leakage and Coagulopathy in Mice with Traumatic Brain Injury.

Research Progress of Von Willebrand Factor for Prevention and Treatment of Ischemic Stroke

Abstract TMP112: Von Willebrand Factor (VWF) Modulates Smooth Muscle Cell Proliferation During the Outward Remodeling of Leptomeningeal Collateral Arterioles Following Stroke

Correlation of von Willebrand factor and platelets with acute ischemic stroke etiology and revascularization outcome: an immunohistochemical study

Vascular Proteomics Reveals Critical Roles of ADAMTS18 in Stroke Associated with Imbalanced Level of Von Willebrand Factor Versus ADAMTS13

Recombinant ADAMTS13 Reduces Tissue Plasminogen Activator‐induced Hemorrhage after Stroke in Mice

Fn-EDA (Fibronectin Containing Extra Domain A) in the Plasma, but Not Endothelial Cells, Exacerbates Stroke Outcome by Promoting Thrombo-Inflammation.

Genetic Drivers of Von Willebrand Factor Levels in an Ischemic Stroke Population and Association with Risk for Recurrent Stroke

Distinct platelet interactions with soluble and immobilized von Willebrand factor modulate platelet adhesion and aggregation with differential impact on hemostasis and thrombosis

von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapy

Adamts13 Controls Vascular Remodeling By Modifying Vwf Reactivity During Stroke Recovery

Relationship between thrombus vWF and NETs with clinical severity and peripheral blood immunocytes' indicators in patients with acute ischemic stroke

Low Density Lipoprotein promotes Microvascular Thrombosis by enhancing von Willebrand Factor Self-association

Abstract WP97: The Aptamer BT200 Blocks Von Willebrand Factor and Platelet Function in Blood of Stroke Patients

Platelet-Derived Factor V Is a Critical Mediator of Arterial Thrombosis.

Von Willebrand factor deficiency and atherosclerosis

Interactions Between Integrin α9β1 and VCAM-1 Promote Neutrophil Hyperactivation and Mediate Post-Stroke DVT

Inhibition of neutrophil rolling and migration by caADAMTS13 in vitro and in mouse models of thrombosis and inflammation